Ishara Investments LP
Filing Date
Global Rank
#7,642
/ 8,794
▲ 269
· as of Jun 2026
Top Industry
Biotechnology
93.0%
Period ended 3 months ago
Filed Aug 14, 2026 · 51d
3 quarters · since Dec 2025
Clone Performance
Build a hypothetical price-return history from this filer's public 13F holdings.
View clone backtestPortfolio Concentration
41 tracked positions · as of Jun 30, 2026 · Δ vs Mar 31, 2026Top Position
7.5%
−7.5 pts
Top 5
30.9%
−7.7 pts
Top 10
50.6%
−6.3 pts
HHI
384
Diversified−148
Portfolio Trend
3 quarters · across all stocks
Sector Breakdown
As of Jun 30, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $138,332,953 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
13 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| ANNX | Annexon, Inc. | +645,750 | 820,000 | $4,682,200 | |
| LXRX | Lexicon Pharmaceuticals, Inc. | +369,000 | 1,271,000 | $3,050,400 | |
| ACAD | Acadia Pharmaceuticals Inc | +287,000 | 410,000 | $10,373,000 | |
| XERS | Xeris Biopharma Holdings, Inc. | +205,000 | 1,230,000 | $9,741,600 | |
| DBVT | DBV Technologies S.A. | +82,000 | 184,500 | $3,025,800 | |
| SION | Sionna Therapeutics, Inc. | +73,800 | 123,000 | $5,410,770 | |
| CTNM | Contineum Therapeutics, Inc. | +63,000 | 205,000 | $3,359,950 | |
| BMRN | Biomarin Pharmaceutical Inc | +61,500 | 143,500 | $8,211,070 | |
| RARE | Ultragenyx Pharmaceutical Inc. | +30,750 | 205,000 | $6,844,950 | |
| PCVX | Vaxcyte, Inc. | +24,600 | 82,000 | $4,766,660 | |
| MLYS | Mineralys Therapeutics, Inc. | +20,500 | 102,500 | $2,765,450 | |
| ORIC | Oric Pharmaceuticals, Inc. | +20,500 | 123,000 | $1,332,090 | |
| GMAB | Genmab A/S | +20,500 | 102,500 | $2,815,675 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
9 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| ZNTL | Zentalis Pharmaceuticals, Inc. | −205,000 | 1,025,000 | $4,971,250 | |
| IMTX | Immatics N.V. | −123,000 | 30,750 | $311,497 | |
| SLN | Silence Therapeutics plc | −85,150 | 55,350 | $607,743 | |
| VERA | Vera Therapeutics, Inc. | −71,750 | 10,250 | $439,827 | |
| TVTX | Travere Therapeutics, Inc. | −28,700 | 82,000 | $4,658,420 | |
| SRRK | Scholar Rock Holding Corp | −26,650 | 30,750 | $1,691,250 | |
| AXSM | Axsome Therapeutics, Inc. | −24,600 | 16,400 | $4,014,228 | |
| PRAX | Praxis Precision Medicines, Inc. | −20,500 | 22,550 | $7,549,514 | |
| BEAM | Beam Therapeutics Inc. | −16,400 | 41,000 | $1,407,120 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
16 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| AGIO | Agios Pharmaceuticals, Inc. | 164,000 | $6,086,040 | |
| INSM | INSMED Inc | 51,250 | $5,464,275 | |
| — | 143,500 | $5,369,770 | ||
| TNXP | Tonix Pharmaceuticals Holding Corp. | 338,250 | $4,316,070 | |
| BBIO | BridgeBio Pharma, Inc. | 57,400 | $4,275,152 | |
| KURA | Kura Oncology, Inc. | 276,750 | $3,035,947 | |
| CYTK | Cytokinetics Inc | 32,800 | $2,794,232 | |
| NUVB | Nuvation Bio Inc. | 369,000 | $2,095,920 | |
| WVE | Wave Life Sciences, Inc. | 328,000 | $1,905,680 | |
| NKTR | Nektar Therapeutics | 26,650 | $1,860,436 | |
| ELVN | Enliven Therapeutics, Inc. | 32,800 | $1,664,600 | |
| VRTX | Vertex Pharmaceuticals Inc / Ma | 2,460 | $1,221,955 | |
| SPRY | ARS Pharmaceuticals, Inc. | 143,490 | $1,149,354 | |
| MNPR | Monopar Therapeutics | 12,300 | $1,138,857 | |
| ERAS | Erasca, Inc. | 41,000 | $751,120 | |
| MREO | Mereo BioPharma Group plc | 768,750 | $244,462 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
11 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| VSTM | Verastem, Inc. | 820,000 | $4,346,000 | |
| ARWR | Arrowhead Pharmaceuticals, Inc. | 55,350 | $3,470,445 | |
| MLTX | MoonLake Immunotherapeutics | 174,250 | $3,248,020 | |
| ARDX | Ardelyx, Inc. | 451,000 | $2,701,490 | |
| LGND | Ligand Pharmaceuticals Inc | 8,200 | $1,637,130 | |
| EWTX | Edgewise Therapeutics, Inc. | 49,200 | $1,549,800 | |
| IDYA | IDEAYA Biosciences, Inc. | 24,600 | $819,672 | |
| PTCT | Ptc Therapeutics, Inc. | 10,250 | $698,332 | |
| — | 82,000 | $0 | ||
| — | 369,000 | $0 | ||
| — | 276,750 | $0 | ||
| No positions match the current search. | ||||
41 tracked positions ·
$138,332,953 total
· filing declares
41 positions · $136,099,277
· as of Jun 30, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| ACAD |
Acadia Pharmaceuticals Inc
Healthcare
|
Added | 410,000 | $10,373,000 | 7.50% | |
| XERS |
Xeris Biopharma Holdings, Inc.
Healthcare
|
Added | 1,230,000 | $9,741,600 | 7.04% | |
| BMRN |
Biomarin Pharmaceutical Inc
Healthcare
|
Added | 143,500 | $8,211,070 | 5.94% | |
| PRAX |
Praxis Precision Medicines, Inc.
Healthcare
|
Reduced | 22,550 | $7,549,514 | 5.46% | |
| RARE |
Ultragenyx Pharmaceutical Inc.
Healthcare
|
Added | 205,000 | $6,844,950 | 4.95% | |
| AGIO |
Agios Pharmaceuticals, Inc.
Healthcare
|
NEW | 164,000 | $6,086,040 | 4.40% | |
| INSM |
INSMED Inc
Healthcare
|
NEW | 51,250 | $5,464,275 | 3.95% | |
| SION |
Sionna Therapeutics, Inc.
Healthcare
|
Added | 123,000 | $5,410,770 | 3.91% | |
|
|
NEW | 143,500 | $5,369,770 | 3.88% | ||
| ZNTL |
Zentalis Pharmaceuticals, Inc.
Healthcare
|
Reduced | 1,025,000 | $4,971,250 | 3.59% | |
| PCVX |
Vaxcyte, Inc.
Healthcare
|
Added | 82,000 | $4,766,660 | 3.45% | |
| ANNX |
Annexon, Inc.
Healthcare
|
Added | 820,000 | $4,682,200 | 3.38% | |
| TVTX |
Travere Therapeutics, Inc.
Healthcare
|
Reduced | 82,000 | $4,658,420 | 3.37% | |
| TNXP |
Tonix Pharmaceuticals Holding Corp.
Healthcare
|
NEW | 338,250 | $4,316,070 | 3.12% | |
| BBIO |
BridgeBio Pharma, Inc.
Healthcare
|
NEW | 57,400 | $4,275,152 | 3.09% | |
| AXSM |
Axsome Therapeutics, Inc.
Healthcare
|
Reduced | 16,400 | $4,014,228 | 2.90% | |
| CTNM |
Contineum Therapeutics, Inc.
Healthcare
|
Added | 205,000 | $3,359,950 | 2.43% | |
| LXRX |
Lexicon Pharmaceuticals, Inc.
Healthcare
|
Added | 1,271,000 | $3,050,400 | 2.21% | |
| KURA |
Kura Oncology, Inc.
Healthcare
|
NEW | 276,750 | $3,035,947 | 2.19% | |
| DBVT |
DBV Technologies S.A.
Healthcare
|
Added | 184,500 | $3,025,800 | 2.19% | |
| GMAB |
Genmab A/S
Healthcare
|
Added | 102,500 | $2,815,675 | 2.04% | |
| CYTK |
Cytokinetics Inc
Healthcare
|
NEW | 32,800 | $2,794,232 | 2.02% | |
| MLYS |
Mineralys Therapeutics, Inc.
Healthcare
|
Added | 102,500 | $2,765,450 | 2.00% | |
| NUVB |
Nuvation Bio Inc.
Healthcare
|
NEW | 369,000 | $2,095,920 | 1.52% | |
| WVE |
Wave Life Sciences, Inc.
Healthcare
|
NEW | 328,000 | $1,905,680 | 1.38% | |
| NKTR |
Nektar Therapeutics
Healthcare
|
NEW | 26,650 | $1,860,436 | 1.34% | |
| SRRK |
Scholar Rock Holding Corp
Healthcare
|
Reduced | 30,750 | $1,691,250 | 1.22% | |
| ELVN |
Enliven Therapeutics, Inc.
Healthcare
|
NEW | 32,800 | $1,664,600 | 1.20% | |
| ALNY |
Alnylam Pharmaceuticals, Inc.
Healthcare
|
Held | 5,125 | $1,542,778 | 1.12% | |
| BEAM |
Beam Therapeutics Inc.
Healthcare
|
Reduced | 41,000 | $1,407,120 | 1.02% | |
| ORIC |
Oric Pharmaceuticals, Inc.
Healthcare
|
Added | 123,000 | $1,332,090 | 0.96% | |
| NAMS |
NewAmsterdam Pharma Co N.V.
Healthcare
|
Held | 36,900 | $1,250,541 | 0.90% | |
| VRTX |
Vertex Pharmaceuticals Inc / Ma
Healthcare
|
NEW | 2,460 | $1,221,955 | 0.88% | |
| SPRY |
ARS Pharmaceuticals, Inc.
Healthcare
|
NEW | 143,490 | $1,149,354 | 0.83% | |
| MNPR |
Monopar Therapeutics
Healthcare
|
NEW | 12,300 | $1,138,857 | 0.82% | |
| ERAS |
Erasca, Inc.
Healthcare
|
NEW | 41,000 | $751,120 | 0.54% | |
| SLN |
Silence Therapeutics plc
Healthcare
|
Reduced | 55,350 | $607,743 | 0.44% | |
| VERA |
Vera Therapeutics, Inc.
Healthcare
|
Reduced | 10,250 | $439,827 | 0.32% | |
| IMTX |
Immatics N.V.
Healthcare
|
Reduced | 30,750 | $311,497 | 0.23% | |
| MREO |
Mereo BioPharma Group plc
Healthcare
|
NEW | 768,750 | $244,462 | 0.18% | |
| GOSS |
Gossamer Bio, Inc.
Healthcare
|
Held | 820,000 | $135,300 | 0.10% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.